THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY
- 1 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 60 (4) , 601-612
- https://doi.org/10.1227/01.neu.0000255350.71700.37
Abstract
OBJECTIVE. Ferumoxytol, an iron oxide nanoparticle that targets phagocytic cells, can be used in magnetic resonance imaging of malignant brain tumors aKeywords
This publication has 33 references indexed in Scilit:
- Characteristics of Ultrasmall Superparamagnetic Iron Oxides in Patients with Brain TumorsAmerican Journal of Roentgenology, 2005
- Pharmacokinetic Study of Ferumoxytol: A New Iron Replacement Therapy in Normal Subjects and Hemodialysis PatientsAmerican Journal of Nephrology, 2005
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug DevelopmentClinical Cancer Research, 2005
- Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate MarkerClinical Cancer Research, 2004
- Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trialJournal of Magnetic Resonance Imaging, 2004
- Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumoursNeuropathology and Applied Neurobiology, 2004
- A New Method for Fast Multislice T1 MappingNeuroImage, 2001
- Isolation and characterization of human malignant glioma cells from histologically normal brainJournal of Neurosurgery, 1997
- Tumor Cell Endocytosis Imaging Facilitates Delineation of the Glioma–Brain InterfaceExperimental Neurology, 1997
- A comparison of one‐shot and recovery methods in T1 imagingMagnetic Resonance in Medicine, 1988